Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,007.30 -25.84 -0.20%
Hang Seng 21,225.90 -0.02 0.00%
S&P/ASX 200 4,814.35 -11.53 -0.24%
  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Prana Biotechnology Ltd

+ Add to Watchlist

PRAN:US

2.3200 USD 0.0200 0.85%

As of 17:20:00 ET on 06/18/2013.

Company Profile for Prana Biotechnology Ltd (PRAN)

Prana Biotechnology Limited is an Australian biotechnology company which researches and develops therapeutic drugs used for treatment of Alzheimer's Disease and other age-related degenerative disorders such as Parkinson's Disease and cataracts.

Contact Information

Prana Biotechnology Ltd

Suite 2
1233 High Street
Armadale, VIC 3143
Australia
Phone: 61-3-9824-8166
Fax: 61-3-9824-8161

Key Executives for Prana Biotechnology Ltd (PRAN)

Geoffrey P KemplerChairman/CEO/FounderRichard RevelinsCFO/Secretary
Diane AngusChief Operating OfficerRudolph E Tanzi "Rudy"Chief Scientific Advisor

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil